Drugs / TOREFORANT
Trials 10 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 15 trials | ||||||
| Phase 1 | NCT01863784 | Apr → Nov 2013 | — | Janssen Research & Development, LLC | Completed | No outcome recorded |
| Phase 1 | NCT01690286 | Oct → Dec 2012 | — | Janssen Research & Development, LLC | Completed | No outcome recorded |
| Phase 1 | NCT01970020 | Oct → Dec 2012 | — | Janssen Research & Development, LLC | Completed | No outcome recorded |
| Phase 1 | NCT01442532 | Sep 2011 → Jul 2012 | — | Janssen Research & Development, LLC | Completed | No outcome recorded |
| Phase 1 | NCT01450982 | Jun → Oct 2011 | rheumatoid arthritis | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Completed | No outcome recorded |
| Phase 25 trials | ||||||
| Phase 2 | NCT02295865 | Nov 2014 → Mar 2016 | psoriasis | Janssen Research & Development, LLC | Completed | No outcome recorded |
| Phase 2 | NCT01823016 | Sep 2013 → Jul 2015 | asthma | Janssen Research & Development, LLC | Completed | No outcome recorded |
| Phase 2 | NCT01862224 | Jul 2013 → Jul 2014 | rheumatoid arthritis | Janssen Research & Development, LLC | Terminated | No outcome recorded |
| Phase 2 | NCT01679951 | Oct 2012 → Apr 2014 | rheumatoid arthritis | Janssen Research & Development, LLC | Terminated | No outcome recorded |
| Phase 2 | NCT00941707 | Feb → Nov 2010 | rheumatoid arthritis | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Terminated | No outcome recorded |
Evidence & citations 8 cited values
Every value below carries the sentence it was read from. 11 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TOREFORANT | ChEMBL registry synonym — accepted as the source's own label CHEMBL3301609 ↗ |
| Known as | JNJ-38518168 | “The purpose of this study is to evaluate the efficacy, tolerability and safety of JNJ-38518168 compared with placebo” NCT00941707 ↗ |
| Known as | JNJ-38518168 HEMITARTRATE | ChEMBL registry synonym — accepted as the source's own label CHEMBL3301609 ↗ |
| Known as | TOREFORANT TARTRATE | ChEMBL registry synonym — accepted as the source's own label CHEMBL3301609 ↗ |
| Action | Inhibit | “Histamine H4 receptor antagonist” CHEMBL3301609 ↗ |
| Modality | Small molecule | — CHEMBL3301609 ↗ |
| Route | Oral | “JNJ-38518168 100 milligram (mg) capsules orally (by mouth) once daily for 12 weeks.” NCT00941707 ↗ |
| Target | HRH4 | “Histamine H4 receptor antagonist” CHEMBL3301609 ↗ |